Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.36 |
| ▸ | LAP3 | P28838 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | EPOR | P19235 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.33 |
| ▸ | KLK1 | P06870 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7025497 | 1.00 | ANPEP (0.36) | ANPEPLAP3L3MBTL1EPORLMNA | |
| SCHEMBL7030950 | 0.84 | KLK1 (0.40) | ANPEPLAP3ELANEKLK1 | |
| SCHEMBL7031540 | 0.74 | SRC (0.38) | ANPEPLAP3L3MBTL1SRCELANE | |
| SCHEMBL1810431 | 0.72 | ANPEP (0.45) | ANPEPLAP3ELANEBTN3A1 | |
| SCHEMBL7026402 | 0.72 | DPP4 (0.35) | ANPEPLAP3L3MBTL1SRCELANE | |
| SCHEMBL643837 | 0.71 | BTN3A1 (0.40) | ANPEPLAP3L3MBTL1LMNASRC | |
| SCHEMBL5996997 | 0.71 | BTN3A1 (0.40) | ANPEPLAP3L3MBTL1LMNASRC | |
| SCHEMBL7021858 | 0.71 | DPP4 (0.37) | ANPEPLAP3L3MBTL1LMNASRC | |
| SCHEMBL5857844 | 0.70 | ELANE (0.40) | ANPEPLAP3L3MBTL1SRCELANE | |
| SCHEMBL7031488 | 0.70 | DPP4 (0.36) | ANPEPLAP3LMNASRCELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1328565-A | Antiviral purine derivatives | UNIV CARDIFF (GB) | 2001-12-26 | — | — | CN | disclosed |